Maryland has hosted 1,775 clinical trials for new medicines targeting six major chronic diseases since 1999, including 369 that are still in the early stages of recruiting patients, according to a study by two pharmaceutical industry groups released Friday.
The report assessed the economic impact of clinical trials in the state, noting that the industry helped support 81,000 jobs, total employee salaries of $1.9 billion and $71 million in Maryland taxes as of 2008.
More than half of the continuing clinical trials in the state are occurring in Baltimore, at the
The major chronic diseases include
The report — titled "Research in your backyard: Developing cures, creating jobs" — was released at a forum at the
The report was prepared by the
In their remarks, the governors emphasized the importance of investing in education and a skilled workforce to attract pharmaceutical companies to their states.
"Progress is a choice," O'Malley said. "Job creation is a choice."
Dr. Edward Bradley, a vice president at
Hopkins was a "good example" of an institution that attracts Phase I clinical trials because of its scientific and medical expertise, Bradley said.